-
Dementia accounts for 13 percent of total UK deaths
pharmatimes
July 20, 2018
New data has revealed that Alzheimer’s disease and other forms of dementia accounted for 13 percent of all UK deaths in 2018.
-
AZ, Lilly pull plug on Alzheimer’s disease trials
pharmatimes
July 10, 2018
Alzheimer’s disease research has taken another hit with the failure of AstraZeneca and Eli Lilly’s experimental (BACE) inhibitor lanabecestat.
-
New leads on treating dementia and Alzheimer's
worldpharmanews
May 04, 2018
A new research study by scientists in Australia and the US provides an explanation for why clinical trials of drugs reducing proteins in the brain that were thought to cause dementia and Alzheimer's have failed.
-
Alzheimer’s drugs market to boost in both developed and developing region markets
pharmaasia
October 16, 2017
Research shows that the Alzheimer’s drugs market is expected to register a substantial expansion by 2025, as awareness also increases.
-
How an eye test could detect Alzheimer's
medicalnewstoday.com
August 24, 2017
Researchers may have brought us a step closer to such a feat, after developing an optical imaging system that can detect a hallmark of Alzheimer's.
-
New target could yield treatment for Alzheimer's, ALS and more
fiercebiotech
August 17, 2017
Researchers led by Genentech have discovered a new drug target for neurodegenerative diseases.
-
Benzodiazepines increase stroke risk in Alzheimer's patients, study finds
pharmafile
January 17, 2017
Benzodiazepines and similar drugs could increase the risk of strokes in Alzheimer’s patients by as much as 20% according to a study from the University of Eastern Finland.